Article Information
History
- November 12, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Eva SL Pedersen1,
- Eugénie NR Collaud1,
- Rebeca Mozun1,2,
- Cristina Ardura-Garcia1,
- Yin Ting Lam1,2,
- Amanda Harris3,
- Jane S Lucas3,4,
- Fiona Copeland5,
- Michele Manion6,
- Bernhard Rindlishbacher7,
- Hansruedi Silberschmidt8,
- COVID-PCD patient advisory group*,
- Myrofora Goutaki1,9 and
- Claudia E Kuehni1,9,†
- 1Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
- 2Graduate School for Cellular and Biomedical Sciences, University of Bern, Switzerland
- 3Primary Ciliary Dyskinesia Centre, NIHR Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK
- 4University of Southampton Faculty of Medicine, Academic Unit of Clinical and Experimental Medicine, Southampton, UK
- 5PCD Family Support Group, Ciliopathy Alliance, London, UK
- 6PCD Foundation, Minneapolis, Minnesota
- 7Selbsthilfegruppe Primäre Ciliäre Dyskinesie, Switzerland
- 8Vorstand / Schriftführer des deutschen Vereins Kartagener Syndrom und Primäre Ciliäre Dyskinesie e. V.; PCD-betroffen
- 9Paediatric Respiratory Medicine, Children’s University Hospital of Bern, University of Bern, Switzerland
- ↵†Corresponding author
Claudia E Kuehni, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland, Mittelstrasse 43, 3012 Bern, Claudia.kuehni{at}ispm.unibe.ch
Author contributions: CE Kuehni, E Pedersen, B Rindlisbacher, J S Lucas, M Goutaki, F Copeland, H Silberschmidt, A Harris, M Manion designed the study. E Pedersen, E Collaud, R Mozun, Y T Lam, C Ardura, M Goutaki, built the database and collected data. E Pedersen drafted the manuscript. All authors contributed to iterations and approved the final version.
Posted November 12, 2020.
COVID-PCD – a participatory research study on the impact of COVID-19 in people with Primary Ciliary Dyskinesia
